From: Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery
All patients documented | PS matched cohort | ||||||
---|---|---|---|---|---|---|---|
Total N = 1357 | Isolated MVS N = 1165 | MVS + TVR N = 192 | p-value | Isolated MVS N = 182 | MVS + TVR N = 182 | p-value | |
Age (years) | 63.9 ± 12.3 | 63.0 ± 12.5 | 69.2 ± 10.1 | < 0.001 | 69.4 ± 10.9 | 68.9 ± 10.2 | 0.623 |
Female gender, % | 43.3 | 40.9 | 58.3 | < 0.001 | 57.7 | 57.7 | 1.000 |
Body mass index (kg/m2) | 26.4 ± 4.7 | 26.4 ± 4.6 | 26.3 ± 5.1 | 0.807 | 26.1 ± 25.7 | 26.3 ± 5.1 | 0.716 |
Cardiovascular risk factors | |||||||
Hypertension, % | 53.7 | 53.2 | 56.8 | 0.360 | 51.6 | 57.1 | 0.292 |
Dyslipidaemia, % | 16.8 | 17.2 | 14.7 | 0.390 | 13.7 | 15.5 | 0.640 |
Diabetes mellitus, % | 8.7 | 8.0 | 13.0 | 0.022 | 9.9 | 13.7 | 0.256 |
Comorbidities - general | |||||||
Creatinine (mg/dL) | 1.0 ± 0.5 | 1.0 ± 0.4 | 1.1 ± 0.6 | < 0.001 | 1.1 ± 0.4 | 1.1 ± 0.5 | 0.518 |
Kidney failure (Cr > 2.26 mg/dL), % | 1.7 | 1.3 | 4.2 | 0.010 | 3.3 | 3.3 | 1.000 |
Stroke, % | 5.5 | 5.3 | 6.3 | 0.600 | 4.9 | 6.0 | 0.645 |
COPD, % | 11.8 | 11.7 | 12.5 | 0.742 | 11.0 | 12.6 | 0.626 |
PAD, % | 3.0 | 2.7 | 4.7 | 0.145 | 4.4 | 4.4 | 1.000 |
Comorbidity – cardiac | |||||||
Atrial fibrillation, % | 32.4 | 28.3 | 57.6 | < 0.001 | 48.9 | 56.0 | 0.172 |
Coronary artery disease, % | 10.2 | 9.9 | 12.5 | 0.266 | 12.6 | 12.6 | 1.000 |
Myocardial infarction (≤90 days), % | 0.7 | 0.6 | 1.0 | 0.371 | 0.0 | 1.1 | 0.499 |
Prior aortic valve replacement, % | 2.1 | 1.4 | 6.3 | < 0.001 | 2.2 | 3.8 | 0.358 |
Prior CABG, % | 3.9 | 3.5 | 6.3 | 0.070 | 7.1 | 5.5 | 0.518 |
Prior pacemaker, % | 2.2 | 1.6 | 5.8 | 0.002 | 2.7 | 6.0 | 0.125 |
NYHA class III / IV, % | 75.5 | 72.6 | 92.2 | < 0.001 | 96.2 | 92.9 | 0.168 |
CCS class III / IV, % | 4.1 | 3.9 | 5.2 | 0.381 | 5.5 | 5.5 | 1.000 |
Pulmonary hypertension, % | 12.0 | 11.3 | 16.7 | 0.033 | 12.6 | 15.9 | 0.369 |
Emergency indication for surgery, % | 3.9 | 4.3 | 1.6 | 0.070 | 1.1 | 1.6 | 1.000 |
Log EuroSCORE I, % | 3.8 [1.9–9.0] | 3.4 [1.6–7.8] | 8.0 [4.0–14.3] | < 0.001 | 6.6 [3.3–14.3] | 7.4 [3.9–12.4] | 0.699 |